Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 217 participants.
Also called NCT01802619
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 1/2
- Enrolled
- 217 participants
- Sponsor
- Registry
-
NCT01802619
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01802619. Randomized; double masking; primary purpose prevention. Start 2013-08 (actual); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.
- Condition
- Heart Valve Diseases
- Condition
- Heart; Complications, Valve, Prosthesis
- Condition
- Cardiac Valve Replacement Complication
- Intervention (Other)
- inhaled nitric oxide
- Intervention (Other)
- inhaled Nitrogen
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct01802619- Content hash
20cb812f56b7f368e49aacaec9e25501fde23098f3ff3459bf03b69f1db5a89d